Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

被引：238

作者：

Stumpf, Julian ^{[1
,40
]}

Siepmann, Torsten ^{[2
]}

Lindner, Tom ^{[3
]}

Karger, Claudia ^{[4
]}

Schwoebel, Joerg ^{[5
]}

Anders, Leona ^{[6
]}

Faulhaber-Walter, Robert ^{[7
]}

Schewe, Jens ^{[8
]}

Martin, Heike ^{[9
]}

Schirutschke, Holger ^{[10
]}

Barnett, Kerstin ^{[11
]}

Huether, Jan ^{[12
]}

Mueller, Petra ^{[13
]}

Langer, Torsten ^{[14
]}

Pluntke, Thilo ^{[15
]}

Anding-Rost, Kirsten ^{[16
]}

Meistring, Frank ^{[17
]}

Stehr, Thomas ^{[18
]}

Pietzonka, Annegret ^{[19
]}

Escher, Katja ^{[20
]}

Cerny, Simon ^{[21
]}

Rothe, Hansjorg ^{[22
]}

Pistrosch, Frank ^{[23
]}

Seidel, Harald ^{[24
]}

Paliege, Alexander ^{[1
]}

Beige, Joachim ^{[4
,25
]}

Bast, Ingolf ^{[6
]}

Steglich, Anne ^{[1
]}

Gembardt, Florian ^{[1
]}

Kessel, Friederike ^{[1
]}

Kroeger, Hannah ^{[1
]}

Arndt, Patrick ^{[1
]}

Sradnick, Jan ^{[1
]}

Frank, Kerstin ^{[26
]}

Klimova, Anna ^{[27
]}

Mauer, Rene ^{[28
]}

Graehlert, Xina ^{[29
]}

Anft, Moritz ^{[30
,31
]}

Blazquez-Navarro, Arturo ^{[30
,31
]}

Westhoff, Timm H. ^{[32
]}

Stervbo, Ulrik ^{[30
,31
]}

Tonn, Torsten ^{[33
,34
]}

Babel, Nina ^{[30
,31
,35
,36
,37
,38
,39
]}

Hugo, Christian ^{[1
,40
]}

机构：

[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 3, Dresden, Germany

[2] Krankenhaus Kuhwald, KfH Nierenzentrum, Klinikum Chemnitz, Dresden, Germany

[3] Univ Hosp Leipzig, Div Nephrol, Leipzig, Germany

[4] Klinikum St Georg, KfH Nierenzentrum, Leipzig, Germany

[5] Dialysezenturm Chemnitz, Chemnitz, Germany

[6] Dialysepraxis Leipzig, Leipzig, Germany

[7] Nephrol Zentrum Freiberg, Freiberg, Germany

[8] Dialyse & Nierenambulanz Sebnitz, Sebnitz, Germany

[9] Nephrol Zentrum Zwickau, Zwickau, Germany

[10] PHV Dialysezentrum Dresden Friedrichstadt, Dresden, Germany

[11] Dialyse Heidenau, Heidenau, Germany

[12] Nephrocare GmbH Dobeln, Dobeln, Germany

[13] PHV Dialysezentrum Dresden Johannstadt, Dresden, Germany

[14] Dialysezentrum Annaberg, Annaberg Buchholz, Germany

[15] KfH Nierenzentrum Grimma, Grimma, Germany

[16] KfH Nierenzentrum Bischofswerda, Bischofswerda, Germany

[17] Stadt Klinikum Gorlitz, KfH Nierenzentrum, Gorlitz, Germany

[18] KfH Nierenzentrum Bautzen, Bautzen, Germany

[19] Via Medis Nierenzentrum Dresden MVZ GmbH, Dresden, Germany

[20] KfH Gesundheitszentrum Aue, Aue Bad Schlema, Germany

[21] ELBLAND Dialyse Grossenhain, Grossenhain, Germany

[22] Dialyse Praxis Weiwasser, Weiwasser, Germany

[23] Nephrol Zentrum Hoyerswerda, Hoyerswerda, Germany

[24] Vogtland Krankenhaus Plauen, KfH Nierenzentrum, Plauen, Germany

[25] Martin Luther Univ Halle Wittenberg, Dept Nephrol & Rheumatol, Internal Med 2, Halle, Germany

[26] DRK Blutspendedienst Nord Ost Gemeinnutzige GmbH, Inst Transfus Med Plauen, Plauen, Germany

[27] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany

[28] Tech Univ, Fac Med Carl Gustav Carus, Inst Med Informat & Biometry IMB, Dresden, Germany

[29] Coordinating Ctr Clin Trials, Dresden, Germany

[30] Ruhr Univ Bochum, Ctr Translat Med, Med Dept 1, Marien Hosp Herne,Univ Hosp, Bochum, Germany

[31] Ruhr Univ Bochum, Univ Hosp, Marien Hosp Herne, Med Dept 1,Immune Diagnost Lab, Bochum, Germany

[32] Ruhr Univ Bochum, Marien Hosp Herne, Med Dept 1, Univ Hosp, Herne, Germany

[33] German Red Cross Blood Donat Serv North East, Inst Transfus Med, Dresden, Germany

[34] Tech Univ, Fac Med Carl Gustav Carus, Transfus Med, Dresden, Germany

[35] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany

[36] Free Univ Berlin, Berlin, Germany

[37] Humboldt Univ, Berlin, Germany

[38] Berlin Inst Hlth, Berlin, Germany

[39] Inst Med Immunol, Berlin, Germany

[40] KfH Nierenzentrum Dresden, Dresden, Germany

来源：

LANCET REGIONAL HEALTH-EUROPE | 2021年 / 9卷

关键词：

epidemiology; COVID-19; SARS-CoV-2; vaccination; mRNA-1273; BNT162b2; tozinameran; dialysis patients; kidney transplant recipients; medical personnel; humoral and cellular immune response; clinical decision-making; guidelines; COVID-19; RECIPIENTS; SPIKE;

D O I：

10.1016/j.lanepe.2021.100178

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Background: Dialysis and kidney transplant patients are vulnerable populations for COVID-19 related disease and mortality. Methods: We conducted a prospective study exploring the eight week time course of specific cellular (interferon-g release assay and flow cytometry) or/and humoral immune responses (ELISA) to SARS-CoV-2 boost vaccination in more than 3100 participants including medical personnel, dialysis patients and kidney transplant recipients using mRNA vaccines BNT162b2 or mRNA-1273. Results: SARS-CoV-2-vaccination induced seroconversion efficacy in dialysis patients was similar to medical personnel (> 95%), but markedly impaired in kidney transplant recipients (42%). T-cellular immunity largely mimicked humoral results. Major risk factors of seroconversion failure were immunosuppressive drug number and type (belatacept, MMF-MPA, calcineurin-inhibitors) as well as vaccine type (BNT162b2 mRNA). Seroconversion rates induced by mRNA-1273 compared to BNT162b2 vaccine were 97% to 88% (p < 0.001) in dialysis and 49% to 26% in transplant patients, respectively. Specific IgG directed against the new binding domain of the spike protein (RDB) were significantly higher in dialysis patients vaccinated by mRNA-1273 (95%) compared to BNT162b2 (85%, p < 0.001). Vaccination appeared safe and highly effective demonstrating an almost complete lack of symptomatic COVID-19 disease after boost vaccination as well as ceased disease incidences during third pandemic wave in dialysis patients. Conclusion: Dialysis patients exhibit a remarkably high seroconversion rate of 95% after boost vaccination, while humoral response is impaired in the majority of transplant recipients. Immunosuppressive drug number and type as well as vaccine type (BNT162b2) are major determinants of seroconversion failure in both dialysis and transplant patients suggesting immune monitoring and adaption of vaccination protocols. (C) 2021 The Authors. Published by Elsevier Ltd.

引用

页数：11

共 50 条

[31] Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis
Benucci, Maurizio
Damiani, Arianna
Li Gobbi, Francesca
Lari, Barbara
Grossi, Valentina
Infantino, Maria
Manfredi, Mariangela
IMMUNOLOGIC RESEARCH, 2022, 70 (04) : 493 - 500
[32] Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors
Venerito, Vincenzo
Stefanizzi, Pasquale
Fornaro, Marco
Cacciapaglia, Fabio
Tafuri, Silvio
Perniola, Simone
Iannone, Florenzo
Lopalco, Giuseppe
RMD OPEN, 2022, 8 (01):
[33] Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection
La Verde, Nicla
Riva, Agostino
Cona, Maria Silvia
Gabrieli, Arianna
Cattaneo, Monica
Fasola, Cinzia
Lipari, Giuseppe
De Stradis, Claudia
Favorito, Valentina
Stocchetti, Benedetta Lombardi
Chizzoniti, Davide
Covizzi, Alice
Rulli, Eliana
Galli, Francesca
Ruggieri, Lorenzo
Gambaro, Anna
Ferrario, Sabrina
Dalu, Davide
Tarkowski, Maciej S.
INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (04) : 661 - 671
[34] 9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients
Stumpf, Julian
Anders, Leona
Siepmann, Torsten
Schwoebel, Joerg
Karger, Claudia
Lindner, Tom
Faulhaber-Walter, Robert
Langer, Torsten
Escher, Katja
Anding-Rost, Kirsten
Seidel, Harald
Huether, Jan
Pistrosch, Frank
Martin, Heike
Schewe, Jens
Stehr, Thomas
Meistring, Frank
Paliege, Alexander
Schneider, Daniel
Bast, Ingolf
Steglich, Anne
Gembardt, Florian
Kessel, Friederike
Kroeger, Hannah
Arndt, Patrick
Sradnick, Jan
Frank, Kerstin
Skrzypczyk, Sarah
Anft, Moritz
Klimova, Anna
Mauer, Rene
Roeder, Ingo
Tonn, Torsten
Babel, Nina
Hugo, Christian
VACCINE, 2024, 42 (02) : 120 - 128
[35] Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
Appelman, Brent
van der Straten, Karlijn
Lavell, A. H. Ayesha
Schinkel, Michiel
Slim, Marleen A.
Poniman, Meliawati
Burger, Judith A.
Oomen, Melissa
Tejjani, Khadija
Vlaar, Alexander P. J.
Wiersinga, W. Joost
Smulders, Yvo M.
van Vught, Lonneke A.
Sanders, Rogier W.
van Gils, Marit J.
Bomers, Marije K.
Sikkens, Jonne J.
EBIOMEDICINE, 2021, 72
[36] Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection
Psichogiou, Mina
Karabinis, Andreas
Poulakou, Garyphallia
Antoniadou, Anastasia
Kotanidou, Anastasia
Degiannis, Dimitrios
Pavlopoulou, Ioanna D.
Chaidaroglou, Antigoni
Roussos, Sotirios
Mastrogianni, Elpida
Eliadi, Irene
Basoulis, Dimitrios
Petsios, Konstantinos
Leontis, Konstantinos
Kakalou, Eleni
Protopapas, Konstantinos
Jahaj, Edison
Pratikaki, Maria
Syrigos, Konstantinos N.
Lagiou, Pagona
Gogas, Helen
Tsiodras, Sotirios
Magiorkinis, Gkikas
Paraskevis, Dimitrios
Sypsa, Vana
Hatzakis, Angelos
VACCINES, 2021, 9 (09)
[37] Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine
Dias, Leonor
Soares-Dos-Reis, Ricardo
Meira, Joao
Ferrao, Diana
Soares, Pedro Ribeirinho
Pastor, Ana
Gama, Guilherme
Fonseca, Luisa
Fagundes, Vitor
Carvalho, Marta
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (08)
[38] Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study
Papadokostaki, Eleni
Tentolouris, Anastasios
Anastasiou, Ioanna A.
Psichogiou, Mina
Iliaki, Evangelia
Eleftheriadou, Ioanna
Hatzakis, Angelos
Tentolouris, Nikolaos
VACCINES, 2022, 10 (03)
[39] Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)
Korth, Johannes
Jahn, Michael
Dorsch, Oliver
Anastasiou, Olympia Evdoxia
Sorge-Haedicke, Burkhard
Eisenberger, Ute
Gaeckler, Anja
Dittmer, Ulf
Witzke, Oliver
Wilde, Benjamin
Dolff, Sebastian
Kribben, Andreas
VIRUSES-BASEL, 2021, 13 (05):
[40] Waning of 2-Dose BNT162b2 and mRNA-1273 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Accounting for Depletion-of-Susceptibles Bias
Andrejko, Kristin L.
Pry, Jake M.
Myers, Jennifer F.
Mehrotra, Megha
Lamba, Katherine
Lim, Esther
Fukui, Nozomi
DeGuzman, Jennifer L.
Openshaw, John
Watt, James
Jain, Seema
Lewnard, Joseph A.
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2023, 192 (06) : 895 - 907

← 1 2 3 4 5 →